Blog
Why Venture Global Rocketed Higher on Monday
Shares of Venture Global (NYSE: VG) rallied 16.6% on Monday, as of 12:18 p.m. EDT.
Venture Global reported an earnings beat this morning, but, ironically, that likely only played a minor role in the
Nvidia Plans to Release a New Speedier AI Chip That Could Be a Game Changer
Nvidia (NASDAQ: NVDA) has been one of the undeniable winners of the artificial intelligence (AI) revolution. The company's graphics processing units (GPUs) quickly became the gold standard for
CHAT vs. SOXX: Which AI ETF Is the Better Buy for Investors Right Now?
The iShares Semiconductor ETF (NASDAQ:SOXX) and the Roundhill Investments - Generative AI & Technology ETF (NYSEMKT:CHAT) both offer exposure to the tech sector, but with different approaches.
SOXX
Better Large-Cap ETF: iShares' IVV vs. Vanguard's MGK
The Vanguard Mega Cap Growth ETF (NYSEMKT:MGK) and the iShares Core S&P 500 ETF (NYSEMKT:IVV) differ most sharply on sector exposure, diversification, and income, with IVV offering broader coverage
BofA Survey: AI Bubble Just Became the Biggest Worry for Credit Investors
Right now, one of the biggest debates in the stock market is this: Are artificial intelligence (AI) stocks overvalued? A new survey of institutional credit investors from Bank of America sheds some
Caesars Stock Has Tanked 27%, but One Fund Just Built a $74 Million Position
On February 17, 2026, Cooper Creek Partners Management acquired a new stake in Caesars Entertainment (NASDAQ:CZR), purchasing 3,170,216 shares worth $74.15 million in the fourth quarter.
According
This $129 Million Bath & Body Works Stake Got Liquidated as Firm Cut Outlook Amid $1.6 Billion Quarter
On February 17, 2026, Cooper Creek Partners Management reported selling out of Bath & Body Works (NYSE:BBWI) shares worth an estimated $128.98 million.
According to a February 17, 2026, SEC filing
Better International ETF: iShares' IXUS vs. Schwab's SCHE
The Schwab Emerging Markets Equity ETF (NYSEMKT:SCHE) and the iShares Core MSCI Total International Stock ETF (NASDAQ:IXUS) differ most in geographic reach, recent performance, and sector makeup
Investment Accounts for Kids
In this podcast, Motley Fool personal finance expert Robert Brokamp discusses the pros and cons of five of the most common options, including the new Trump accounts.
Also in this episode:
To catch
Warren Buffett Hit the Buy Button for $965,291,328 Late Last Year. Berkshire Now Owns Nearly 9.3% of This Leading Insurer.
Warren Buffett was apparently pretty bearish on the stock market late last year. The company he led as CEO until year end, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), was holding a record amount
Rule Breaker Investing Pet Peeves, Vol. 9
This edition of Rule Breaker Investing digs in on:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10
StealthGas (GASS) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, March 2, 2026 at 10 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Buying This 1 Pharmaceutical Stock Today Could Make You a Multimillionaire Retiree
Over the past decade, Eli Lilly (NYSE: LLY) has produced amazing returns, becoming the largest healthcare stock in the world in the process -- and the first to hit a $1 trillion valuation. Lilly may
CoreWeave: After Dropping 18%, Is It a Stock to Avoid or Once-in-a-Decade Buying Opportunity?
CoreWeave (NASDAQ: CRWV) was one of last year's biggest artificial intelligence (AI) success stories, and the company's revenue strength continues. The cloud player launched its initial public
PayPal Buyout Rumors
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When
Trying to Get the $5,251 Max Social Security Benefit Is Overrated. Do This Instead.
Let's be honest: We all want the $5,251 max Social Security benefit. That kind of money, coupled with any personal savings you've managed to scrape together, could give most people a comfortable
Could Investing $10,000 in Circle (CRCL) Stock Make You a Millionaire?
Circle Internet Group (NYSE: CRCL), the issuer of the USD Coin (CRYPTO: USDC) stablecoin, went public last June at $31 per share. Its stock now trades at nearly $94. Could investing $10,000 in this
Why Planet Labs Stock Popped Today
Planet Labs (NYSE: PL) stock jumped 8.6% through 12:15 p.m. ET Monday -- and it's not hard to figure out why.
Over the weekend, war broke out among the United States, Israel, and Iran. Most denizens
Want $1 Million In Retirement? Invest $100 a Month in These 3 Stocks and Don't Look Back.
Building a million-dollar retirement portfolio takes a combination of three things. You need to invest enough money into investments that are generating a high enough return to reach that target by
Unexpected Stock Picks and Looking to the Future
In this podcast, Motley Fool contributors Rick Munarriz, Jason Hall, and Travis Hoium dive into stocks that they are willing to give up their Fool card for. There's also a look at how they think the
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
Palo Alto Investors LP disclosed an increase of 209,523 shares in Dyne Therapeutics (NASDAQ:DYN) in its 13F filing for the quarter ended December 31, 2025, an estimated $3.97 million trade based on
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing
Palo Alto Investors LP initiated a new position in Compass Therapeutics (NASDAQ:CMPX), buying 2,532,419 shares during the quarter for a position value of $13,599,090 as of December 31, 2025
RadNet (RDNT) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, March 2, 2026 at 10:30 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Kosmos Energy (KOS) Q4 2025 Earnings Transcript
Image source: The Motley Fool.
Monday, Mar. 2, 2026 at 11 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell
If you ask me for a reason I'd buy Pfizer (NYSE: PFE) stock and never sell it, I certainly have one -- because I've already bought into Pfizer, and I have no plans to sell it. Here's a look at why I